Lisdexamfetamine in the treatment of attention-deficit/hyperactivity disorder in adults

Curr Psychiatry Rep. 2009 Oct;11(5):341-2. doi: 10.1007/s11920-009-0064-3.
No abstract available

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Attention Deficit Disorder with Hyperactivity / diagnosis
  • Attention Deficit Disorder with Hyperactivity / drug therapy*
  • Blood Pressure / drug effects
  • Central Nervous System Stimulants / adverse effects
  • Central Nervous System Stimulants / therapeutic use*
  • Dextroamphetamine / adverse effects
  • Dextroamphetamine / therapeutic use*
  • Double-Blind Method
  • Dyspnea / chemically induced
  • Female
  • Headache / chemically induced
  • Humans
  • Irritable Mood / drug effects
  • Lisdexamfetamine Dimesylate
  • Male
  • Middle Aged
  • Sleep Initiation and Maintenance Disorders / chemically induced
  • Tachycardia / chemically induced
  • Treatment Outcome
  • Young Adult

Substances

  • Central Nervous System Stimulants
  • Lisdexamfetamine Dimesylate
  • Dextroamphetamine